« Optical Coherence Tomography Measurement of Retinal Nerve Fiber Layer After Acute Primary Angle Closure With Normal Visual Field | Main | Intrastromal corneal ring helps prevent graft rejection, study says »
May 28, 2006
Ganfort granted EU approval
OSN TOP STORY for May 27, 2006
Allergan’s Ganfort, a combination of bimatoprost and timolol, is indicated for the reduction of IOP in patients with open-angle glaucoma of ocular hypertension, who are insufficiently responsive to topical beta blockers or prostaglandin analogues, Allergan said.
Ganfort has been approved for once-daily dosing, which Allergan said will help improve patient compliance. According to the release, Ganfort showed 40% less hyperemia than bimatoprost monotherapy in clinical trials.
Posted by aman at May 28, 2006 12:47 AM